中国药物经济学
中國藥物經濟學
중국약물경제학
CHINA JOURNAL OF PHARMACEUTICAL ECONOMICS
2014年
7期
212-213
,共2页
药学服务%临床药学%癌症%疼痛
藥學服務%臨床藥學%癌癥%疼痛
약학복무%림상약학%암증%동통
Pharmaceutical services%Clinical pharmacy%Cancer%Pain
目的:研究药学服务对癌症疼痛患者的影响。方法选择我院2012年7月至2013年7月收治的癌症疼痛患者98例为研究对象,随机分为对照组和治疗组,每组49例。对照组给予常规药物治疗与护理,治疗组在此基础上由临床药师对患者提供药学服务。观察两组患者疼痛控制程度、合理用药知识了解程度、医患满意率。结果药学服务干预后的治疗组患者与对照组比较,在疼痛控制、合理用药知识了解、医患满意率上均有明显提高,差异有统计学意义(P<0.05)。结论通过对癌痛患者实施药学服务,能明显提高癌痛患者生活质量,在癌症疼痛规范化治疗中起着重要的作用。
目的:研究藥學服務對癌癥疼痛患者的影響。方法選擇我院2012年7月至2013年7月收治的癌癥疼痛患者98例為研究對象,隨機分為對照組和治療組,每組49例。對照組給予常規藥物治療與護理,治療組在此基礎上由臨床藥師對患者提供藥學服務。觀察兩組患者疼痛控製程度、閤理用藥知識瞭解程度、醫患滿意率。結果藥學服務榦預後的治療組患者與對照組比較,在疼痛控製、閤理用藥知識瞭解、醫患滿意率上均有明顯提高,差異有統計學意義(P<0.05)。結論通過對癌痛患者實施藥學服務,能明顯提高癌痛患者生活質量,在癌癥疼痛規範化治療中起著重要的作用。
목적:연구약학복무대암증동통환자적영향。방법선택아원2012년7월지2013년7월수치적암증동통환자98례위연구대상,수궤분위대조조화치료조,매조49례。대조조급여상규약물치료여호리,치료조재차기출상유림상약사대환자제공약학복무。관찰량조환자동통공제정도、합리용약지식료해정도、의환만의솔。결과약학복무간예후적치료조환자여대조조비교,재동통공제、합리용약지식료해、의환만의솔상균유명현제고,차이유통계학의의(P<0.05)。결론통과대암통환자실시약학복무,능명현제고암통환자생활질량,재암증동통규범화치료중기착중요적작용。
Objective To study the effects of pharmaceutical care for the of patients with cancer pain.Methods Select cancer pain patients from July 2012 to July 2013 treatment in our hospital for the study of 98 cases,the patients were randomly divided into a control group and treatment group 49 cases.The control group received conventional medical treatment and care, the treatment group on the basis of providing pharmaceutical care to patients by a clinical pharmacist.The degree of pain control was observed in patients with both groups,the degree of rational understanding medication knowledge,the doctor-patient satisfaction rate.Results Treatment group compared with the control group after the intervention pharmacy services,has improved significantly in pain control, knowledge about the rational use of drugs, the doctor-patient satisfaction rate,the difference had statisticaly significant(P<0.05).Conclusion Through the implementation of pharmaceutical care of patients with cancer pain,can significantly improve the quality of life of patients with cancer pain, plays an important role in the standardization of the treatment of cancer pain.